GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (NYSE:BHC) » Definitions » Shiller PE Ratio

BHC (Bausch Health) Shiller PE Ratio : (As of Apr. 12, 2025)


View and export this data going back to 1994. Start your Free Trial

What is Bausch Health Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Bausch Health Shiller PE Ratio Historical Data

The historical data trend for Bausch Health's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Shiller PE Ratio Chart

Bausch Health Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bausch Health Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Bausch Health's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bausch Health's Shiller PE Ratio falls into.


;
;

Bausch Health Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Bausch Health's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Bausch Health's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.25/127.3637*127.3637
=0.250

Current CPI (Dec. 2024) = 127.3637.

Bausch Health Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 0.280 99.789 0.357
201506 -0.150 100.500 -0.190
201509 0.140 100.421 0.178
201512 -0.980 99.947 -1.249
201603 -1.080 101.054 -1.361
201606 -0.880 102.002 -1.099
201609 -3.490 101.765 -4.368
201612 -1.470 101.449 -1.846
201703 1.790 102.634 2.221
201706 -0.110 103.029 -0.136
201709 3.690 103.345 4.548
201712 1.450 103.345 1.787
201803 -7.360 105.004 -8.927
201806 -2.490 105.557 -3.004
201809 -1.000 105.636 -1.206
201812 -0.983 105.399 -1.188
201903 -0.150 106.979 -0.179
201906 -0.490 107.690 -0.580
201909 -0.140 107.611 -0.166
201912 -4.299 107.769 -5.081
202003 -0.430 107.927 -0.507
202006 -0.920 108.401 -1.081
202009 0.200 108.164 0.236
202012 -0.430 108.559 -0.504
202103 -1.710 110.298 -1.975
202106 -1.660 111.720 -1.892
202109 0.520 112.905 0.587
202112 0.190 113.774 0.213
202203 -0.190 117.646 -0.206
202206 -0.400 120.806 -0.422
202209 1.100 120.648 1.161
202212 -1.130 120.964 -1.190
202303 -0.550 122.702 -0.571
202306 0.070 124.203 0.072
202309 -1.030 125.230 -1.048
202312 -0.110 125.072 -0.112
202403 -0.170 126.258 -0.171
202406 0.030 127.522 0.030
202409 -0.230 127.285 -0.230
202412 0.250 127.364 0.250

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bausch Health  (NYSE:BHC) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Bausch Health Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Bausch Health's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch Health Business Description

Traded in Other Exchanges
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Executives
Seana Carson officer: EVP, General Counsel 400 SOMERSET CORPORATE BLVD, BRIDGEWATER NJ 08807
John S Barresi officer: SVP, Controller & CAO 727 FIFTH AVENUE, NEW YORK NY 10022
Richard Mulligan director C/O ICAHN CAPITAL LP, 767 FIFTH AVENUE, SUITE 4700, NEW YORK NY 10153
Tom George Vadaketh officer: EVP, Chief Financial Officer 1727 JOCKEYS WAY, YARDLEY PA 19067
Robert Spurr director, officer: U.S. President-Pharma Business C/O BAUSCH HEALTH COMPANIES INC., 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Joseph F Gordon officer: Pres&Co-Head Bausch&Lomb/Int'l C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Frederick Munsch officer: SVP, Controller and CAO C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Christina Ackermann officer: EVP AND GENERAL COUNSEL C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Sam Eldessouky officer: EVP & Chief Financial Officer C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Steven D Miller director 16690 COLLINS AVENUE, PH, SUNNY ISLE BEACH FL 33160
Von Eschenbach Andrew C. director C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
De Schutter Richard U director C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Brett Icahn director C/O ICAHN ENTERPRISES L.P., 16690 COLLINS AVE., PH, SUNNY ISLES FL 33160
William D. Humphries officer: EVP, COMPANY GROUP CHAIRMAN C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE SUITE 140, HORSHAM PA 19044
Valueact Capital Master Fund, L.p. director, other: See remarks ONE LETTERMAN DRIVE, BUILDING D, 4TH FLOOR, SAN FRANCISCO CA 94129